Session X: Presentation of Selected Colorectal Cancer Abstracts
SO-21: Optimal maintenance treatment strategy following an anti-EGFR-based first-line induction therapy in patients with RAS wild type metastatic colorectal cancer: an individual patient data pooled analysis of clinical trials
